Table 4 Clinical characteristics of the validation cohort

Age (years)

2.1 (0.6 to 4.6)

1.4 (0.9 to 8.5)

Males

34 (58)

10 (91)*

Pediatric Risk of Mortality

10 (7 to 117)

25 (10 to 28)*

Deaths^a

2 (3)

2 (19)

   With Gram-negative organism

10 (17)

4 (36)

   With Gram-positive organism

9 (15)

4 (36)

   With negative cultures

40 (68)

3 (27)*